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Abstract
Small arteries are known to develop functional and structural alterations in hypertension.
However, the mechanisms of this remodeling are not fully understood. We hypothesized
that altered gene expression is associated with the development of hypertension in mesen-
teric arteries of spontaneously hypertensive rats (SHR). Three sublines of SHR and normo-
tensive Wistar Kyoto rats (WKY) were studied at 6 weeks and 5 months of age. MiRNA and
mRNA microarray experiments were performed and analyzed with bioinformatical tools,
including Ingenuity Pathway Analysis (IPA). Principal component analysis showed a clear
separation in both miRNA and mRNA expression levels between both ages studied, dem-
onstrating strong age-related changes in expression. At the miRNA level, IPA identified dif-
ferences between SHR andWKY related to metabolic diseases, cellular growth, and
proliferation. The mRNAs differentially expressed between SHR andWKY were related to
metabolism, cellular movement and proliferation. The most strongly upregulated gene (9.2-
fold) was thrombospondin 4 (Thbs4), a protein involved in the endoplasmic reticulum (ER)
stress response that activates transcription factor 6α (ATF6α). ATF6α downstream targets
were also differentially expressed in SHR vs. WKY. Differential expression of THBS4, the
cleaved form of ATF6α, and two of its targets were further confirmed at the protein level by
western blot. In summary, these data revealed a number of genes (n = 202) and miRNAs
(n = 3) in mesenteric arteries of SHR that had not been related to hypertension previously.
The most prominent of these, Thbs4, is related to vascular ER stress that is associated with
hypertension.
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Introduction
Despite ample treatment options, hypertension remains one of the most important risk factors
for cardiovascular disease. Blood pressure levels are tightly related to peripheral resistance,
which is mainly determined by small arteries and arterioles in the vascular bed. These vessels,
referred to as resistance arteries, show structural (remodeling) and functional changes in
hypertension, that may increase peripheral resistance and thereby blood pressure. Such
changes include inward remodeling, hypertrophy, and impaired endothelium-dependent dila-
tion [1].
At the level of the resistance arteries, few studies addressed alterations in gene expression in
a genome wide manner. Thus, previous studies compared mRNA expression between sponta-
neously hypertensive rats (SHR) and its normotensive control, the Wistar Kyoto rat (WKY), in
kidney [2,3], adrenal gland [4], vascular smooth muscle cells [5], and in saphenous arteries[6].
One study compared collateral resistance arteries from the mesenteric vascular bed of SHR and
WKY [7]. None of these studies included the more recently identified miRNAs, which add
another layer of regulation. Therefore, in the current study we tested the hypothesis that gene
expression is altered in the development of hypertension in mesenteric arteries of SHR as com-
pared to WKY. To address this hypothesis, we used miRNA and mRNA microarrays, as well as
bioinformatical analysis.
As a previous study by our group identified differences in remodeling between sublines of
SHR andWKY [8], three sublines of SHR andWKY were used to identify genes that are consis-
tently up or down regulated with hypertension. In addition, to study the change in the expres-
sion pattern during hypertension development, two time points where chosen: 6 weeks of age,
which is considered as a pre-hypertensive stage, and 5 months of age, where hypertension is
established [9]. The data showed differences in miRNA and mRNA expression between SHR
andWKY, as well as between both ages in SHR and in WKY. A number of genes, pathways
and miRNAs that were found to be differentially expressed in mesenteric arteries of SHR vs.
WKY have not been related to hypertension previously.
Materials and Methods
Animals
Male SHR and WKY rats at 6 weeks and 5 months of age (n5 per sub-line and time point)
were obtained from three different locations. The SHR/NCrl, WKY/NCrl, and stroke-prone
SHR animals (SHRSP/A3NCrl) rats were obtained from Charles River, the Netherlands. The
SHR/NHsd and WKY/NHsd rats were derived from Harlan UK, (Bicester, U.K.) and bred at
the local animal facility of the Universidad Autónoma de Madrid, Spain. WKY/NTac rats were
obtained from Taconic Farms (Germantown, NY, USA).We studied male rats in order to mini-
mize variations in gene expression related to the estrous cycle in female rats. All experiments
were approved by the Committee for Animal Experiments of the Academic Medical Center,
Amsterdam. Data on blood pressure and vascular remodeling in this set of animals has been
published previously [8].
Tissue collection
Animals were anesthetized with isoflurane (5%), weighed, heparinized, and blood was taken by
a heart puncture. Animals were then killed by decapitation. The intestines were removed in
block and placed in chilled MOPS buffer. Second- and third-order branches of the mesenteric
artery were dissected using a stereomicroscope. From each animal, two vessels were cleaned
from adipose tissue and blood, leaving the adventitia and endothelium intact. They were stored
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in sterile tubes at -80°C for miRNA and mRNA analysis. Additional vessels were taken for
RT-PCR confirmation.
Microarray analysis
Gene expression was analyzed in WKY and SHR sublines at two ages (6 weeks and 5 months).
For each subline, vessels from five animals were pooled, yielding 12 samples in total. Total
RNA including microRNAs was isolated using the miRNeasy Micro Kit (Qiagen) according to
the manufacturer’s instructions. Integrity of the isolated RNA was evaluated using the RNA
6000 Pico kit and Small RNA kit on a BioAnalyzer system (Agilent Technologies).
For whole transcriptome analysis, 100 ng total RNA per test sample was combined with
Spike A and amplified incorporating Cy3 according to the “Agilent Two-Color Microarray-
Based Gene Expression Analysis Guide” version 6.6 using the Quick Amp Labeling Kit (Agilent
Technologies). As common reference an equimolar pool of all test samples was made of which
100 ng was amplified as described above with the exception that Spike B was included and Cy5
was used for labeling. Synthesized cyanine-dye labeled antisense RNA (aRNA) was purified
using the RNeasy MinElute Cleanup Kit (Qiagen) before measuring yield and dye incorpo-
ration on a NanoDrop ND-1000. Labeled test samples and common reference were combined
and hybridized on SurePrint G3 Rat GE 8x60K microarrays (G4858A-028279, Agilent Tech-
nologies) according to the manufacturer’s instructions.
For miRNA expression analysis, 100 ng of total RNA including microRNAs was labeled
with Cy3 as described in the “miRNAMicroarray System with miRNA Complete Labeling and
Hyb Kit Manual” version 2.2 (Agilent Technologies) with the inclusion of spike-ins and the
optional desalting step with spin columns (Micro Bio-Spin 6, Bio-Rad). Labeled samples were
hybridized on rat 8x15k miRNA microarrays (G4471A-046066, Agilent Technologies), which
are based on Sanger miRbase release 19.0. After washing, the arrays were scanned in an ozone-
free room with an Agilent DNAmicroarray scanner (G2565CA, Agilent Technologies). Data
was extracted with Feature Extraction software v10.7.3.1 (Agilent Technologies) using the miR-
NA_107_Sep09 protocol for miRNA microarrays.
Data analyses were carried out with Bioconductor packages in the statistical software pack-
age R (Version 3.0.0). Separate analyses were performed for the mRNA and miRNA arrays. All
arrays were subjected to a set of quality control checks, such as visual inspection of the scans,
checking for spatial effects through pseudo-color plots, and inspection of pre- and post-nor-
malized data with box plots, density plots, ratio-intensity plots, heatmaps and principal com-
ponent analysis using the arrayQualityMetrics package. Pre-processing and summarization of
miRNA probe-level data was done using a modified version of the robust multi-array average
(RMA) method with background correction, implemented in the AgiMicroRna package. This
pre-processing method has been shown to have better precision than the one recommended by
Agilent [10]. Only non-control miRNAs detected on at least one microarray according to Agi-
lent Feature Extraction software were included in the further analysis. Background correction
of the mRNA arrays was performed using the “normexp”method [11] with an offset of 15 to
adjust the foreground signal without introducing negative values (limma package). The result-
ing log ratios were transformed using intensity-dependent loess normalization (limma pack-
age). Control probes were down-weighted to zero in the normalization step and not included
in the further analysis. Normalized log-ratios for replicate probes were averaged. Probe annota-
tion was downloaded from https://earray.chem.agilent.com/earray/catalogGeneLists.do?
action=displaylist (028279_D_GeneList_20130204.txt).
For both experiments a 2x2 factorial design was used with strain (WKY/SHR) and age (6
weeks/5 months) as factors. Differential expression was assessed by fitting gene-wise linear
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models with a factor containing the 4 conditions as explanatory variable. In the mRNA experi-
ment four samples were hybridized twice. These technical replicates were handled by estimat-
ing a common value for the intra-replicate correlation and including it in the linear model. To
find genes with differential expression between two conditions, we employed a moderated t-
test and adjusted the resulting p-values to correct for multiple hypothesis testing using the Ben-
jamini-Hochberg false discovery rate (FDR). For unsupervised analysis of the mRNA data, nor-
malized log-ratios of technical replicate arrays were averaged. Dendrograms were generated
with Pearson correlation as distance measure, complete linkage as agglomeration method
(function hclust using the 100 miRNAs with highest variance and the genes with an inter-quar-
tile expression range larger than 0.6, respectively.). Principal component analysis was per-
formed on scaled data (function prcomp).
The miRNA and mRNA data have been deposited in the NCBI Gene Expression Omnibus
in a MIAME compliant format and are accessible under GEO Series accession number
GSE53364.
Further analysis of the microarray data was performed to analyze the expression of Atf6α
target genes. The list of targets was obtained from Adachi et al [12] and a ROAST gene set test
[13] was performed to determine whether Atf6 targets were either up or down regulated using
10,000 rotations.
Ingenuity Pathway Analysis (IPA)
IPA software (Ingenuity Systems, http:/www.ingenuity.com), based on gene ontology (GO)
and published literature, was used to identify biological processes, canonical pathways, molecu-
lar functions and genetic networks where the differentially expressed miRNAs or mRNAs from
our microarray data could interact. For the studies, the core analysis tool was used, and the cut-
off log ratio was set to 0.5, so that genes/miRNAs with a log2(fold change)>0.5 or<-0.5 were
selected. As cell lines, smooth muscle cells, endothelial cells and fibroblasts were chosen in the
settings. Top canonical pathways, molecular functions and networks are presented as generated
by the software.
RT-PCR
Quantitative real time PCR was used to evaluate the expression levels of 6 miRNAs and 10
mRNA that emerged as the most up- or down- regulated in the microarray experiments. Sam-
ples of mesenteric arteries were obtained from the same animals fromWKY/NTac and
SHRSP/A3NCrl sublines used for the microarray study. RNA extraction was done using the
miRCURY™ RNA Isolation Kit (Exiqon) according to the manufacturer’s instructions. RNA
integrity and quantification was evaluated using a RNA 6000 Pico Kit in a Bionalyzer system
(Agilent Technologies). RNA with RNA integrity numbers (RIN values)> 7.0 was used for fur-
ther experiments.
For the miRNA, the RNA (5ng/μL) was transcribed to cDNA using the Universal cDNA
synthesis kit II–miRCURY microRNA PCR (Exiqon) following the manufacturer’s instruc-
tions. Then, the cDNA was used for the RT-PCR using the Exilent SYBR Green master mix
(Exiqon) and miRCURY LNA Universal RT microRNA PCR primers set (Exiqon) for the fol-
lowing miRNAs: rno-miR-29b-3p, rno-miR-31a-5p, rno-miR-542-5p, rno-miR-31a-3p, rno-
miR-146a-5p, rno-miR-132-3p and U6 as reference miRNA. The PCR program started with an
activation/denaturalization step at 95°C followed by 40 amplification cycles of 10 seconds at
95°C and 60°C for 60 seconds. For mRNA, the RNA (500 ng) was reverse transcribed into dou-
ble stranded cDNA using the Ovation Pico WTA System V2 kit (NuGEN) following the manu-
facturer’s instructions. The template cDNA was amplified using specific forward and reverse
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primers for every gene (Table 1), in combination with SensiFAST SYBR & fluorescein kit (Bio-
line). The PCR program consisted of an initial heating step (95°C) of 3 minutes to activate the
polymerase. Subsequently, 40 amplification cycles of 5 seconds at 95°C and 30 minutes at 65°C
allowed denaturation of the DNA and DNA synthesis, respectively, and were followed by a
final step of 1 min at 95°C and 1 minute at 65°C. In both cases, after the amplification cycles, a
dissociation curve was performed by measuring fluorescence from 65°C until 95°C in steps of
0.5°C. Fluorescence was measured with a iCycler iQ™ detection system (Bio-Rad) and the data
was analyzed with myiQ 2.0 software (Bio-Rad). Gene expression was normalized to the refer-
ence gene P0 (ribosomal protein large P0). Every experiment included duplicate control reac-
tions and all genes were determined for every sample.
Immunohistochemistry
Segments of mesenteric arteries were embedded, frozen and cut into 5μm sections. The sections
were then fixed in methanol 100% for 20 minutes. Next, a blocking step consisting of a 45 min-
utes incubation with 3% bovine serum albumin (BSA) + 0.005% triton X was applied at room
temperature. After that, sections were incubated overnight at 4°C with the primary antibody,
rabbit anti-rat thrombospondin 4 (Santa Cruz sc-7657-R; 1:100). Samples without primary
antibody were used as negative control. After washing, the samples were incubated for 45 min-
utes at room temperature with secondary antibody, a goat anti-rabbit Cy3-labelled (Brunsch-
wig 111-165-144) in a 1:300 dilution in 1% BSA. Incubation with bisbenzimide (3.5 mg/ml) at
Table 1. Real-time PCR primers used for validation of microarray data.
Gene symbol Gene name Primer forward/reverse
P0 Ribosomal protein large P0 CACAGAAGGGTCCTGGCTTTGTCTGTG
CGCAAATGCAGATGGATCG
Pcmtd1 Protein-L-isoaspartate(D-aspartate) O-methyltransferase AGCCTTCAGAGCCATTGACC
domain containing 1 CGCATAATCTGTGTCAACTGATCC
Ano1 Anoctamin 1, calcium activated chloride channel GAGATCGGCATCCCGAAGAT
GTGCATGGTCCCGTTTTGAC
Enpp1 Ectonucleotide pyrophosphatase/phosphodiesterase 1 GTGGTACAAAGGACAGCCGA
GCCTTGATGACCTCACTGCT
α-globin Alpha Globin CTGCTGAAATTGGCGCAGAG
GCAGTGGCTCAGGAACTTGAA
Thbs4 Thrombospondin 4 CAGAGCCACACAGAGGCTGTC
GCAGAAGGTCAAAGACCTGGG
LOC302022 Similar to nidogen 2 protein AGGTCCGAGTGGGCGTCT
GAGATGATCCCATTGGTGCCC
Dio3 Deiodinase, iodothyronine, type III CACGGGGAACCGTCAAAAAC
AGTCCTAGCCTCCCTCTTGG
Esm1 Endothelial cell-speciﬁc molecule 1 CCAAACAGAGCGCGATGC
CCAGGATCAGCGCGGATTTA
Mettl24 Methyltransferase like 24 CGCCTCTACTCTTTAGGGCTG
GGCACTTTCCAGATCTGCCT
Sltrk5 SLIT and NTRK-like family, member 5 AGTACAGCGTCTATGGGGGT
CCTCCACGGAATTGCCTTCT
Gene symbols, names and sequences of the primers used for the validation of the microarray data.
doi:10.1371/journal.pone.0137027.t001
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1:100 dilution during 3 minutes was used to visualize the nuclei. Sections were covered with
DAKO fluorescent mounting medium (DAKO–S3023) and coverslipped.
Western Blot
Frozen aortae were pulverized in a Tissuelyser LT (Qiagen). Tissue powder was dissolved in
sample buffer (62.5 mM Tris-HCl pH 6.8, 2% SDS (W/V), 10% (V/V) glycerol, 5% (V/V) mer-
captoethanol) containing phosphatase and protease inhibitors (Sigma, St. Louis, USA). Protein
concentration was determined using the Bio Rad DCprotein assay and 20 μg protein was
loaded in the wells of precast AnyKD gels (TGX Criterion, Bio Rad, Hercules, CA, USA). Fol-
lowing separation in Tris-Glycine buffer, proteins were transferred to membranes (0.2 μm
nitrocellulose) using the Turboblot system (Bio Rad), blocked in casein buffer (Bio Rad),
washed (20 mM Tris-HCl, 0.5 M NaCl, 0.05% (v/v) Tween 20, pH 7.5), and incubated with pri-
mary antibodies raised against THBS4 (sc-390734, Santa Cruz, 1:100;), ATF6α (ab11909
abcam, 1:250), MANF (ab67271 abcam, 1:500) and PDI (#3501 Cell Signaling, 1:1000), all
added directly to the blocking buffer. After washing and incubation with horseradish peroxi-
dase-conjugated secondary antibodies (Cell Signaling Technology, Danvers, MA, USA) blots
were developed using West Femto substrate (Pierce, Rockford, IL) and captured using the
Odessey Fc instrument (LI-COR Biosciences). Because the loading controls tested changed in
hypertension vs. normotension, bands were normalized to protein remaining on the gels after
transfer, as shown previously [14]. Protein was detected using Biosafe Coomassie G-250 stain.
Statistical analysis
Statistical analysis for the microarray was explain in the microarray analysis methods section.
For other parameters, the software GraphPad Prism 5 (GraphPad Software Inc.) was used. In
the case of the PCR experiments performed for validation of the microarray data, differences
between WKY and SHR were tested using Mann–Whitney U test.
Results
Principal component analysis
We analyzed miRNA and mRNA expression in mesenteric arteries of WKY rats and SHR at 6
weeks and 5 months of age. These time points were chosen with the objective of representing a
pre-hypertensive stage and a phase of established hypertension. During the analysis, all
miRNA samples passed quality control. However, in the mRNA experiment, two out of the
twelve samples did not pass quality control, and were therefore excluded from further analysis
(WKY/NHsd and SHR/NHsd at 5 months of age). Principal component analysis and hierarchi-
cal clustering of both miRNA and mRNA expression showed a clear separation between young
and mature rats, indicating an overall pattern of age-related changes in expression (Fig 1).
WKY and SHR were less clearly separated in the principal component analysis and hierarchical
clustering, indicating a weaker relationship of miRNA and mRNA expression with hyperten-
sion than with maturation.
Differential expression
From a total number of 307 miRNAs that were tested, WKY showed significant differential
expression (FDR<0.05) of 56 miRNAs when comparing young (6 weeks) and mature (5
months) rats (Fig 2A). In SHR, 96 miRNAs were significantly differentially expressed upon
maturation. Of these, 46 miRNAs were shared between WKY and SHR (Fig 2A). The most
strongly up- and down-regulated miRNAs are listed in Table 2. A direct comparison of WKY
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and SHR miRNA expression profiles showed only few differences between WKY and SHR.
Only miR-31a-3p and miR-31a-5p were significantly upregulated in SHR at both 6 weeks and
5 months of age. In addition, at 5 months of age a significant decrease in the expression of
miR-146a-5p was found in SHR as compared to WKY (Fig 2B).
At the mRNA level we tested 30367 genes, of which 55 were differentially expressed in
WKY when comparing expression at 6 weeks to 5 months of age. In SHR, a much larger set of
313 genes were differentially expressed upon maturation, representing approximately 1% of
the genes probed on the microarray (Fig 2C). Among the age-related genes, 31 genes were
shared between WKY and SHR (Fig 2C). Genes specific for maturation of either WKY or SHR
Fig 1. Principal component analysis and hierarchical clustering.miRNA (panel A) and mRNA expression (panel B) were analyzed in mesenteric arteries
fromWKY and SHR sublines at 6 weeks and 5 months of age. A clear clustering of age groups was observed, indicating strong age-related gene expression.
Note that in panel A, theWKY/NHsd (5 months) stands out. In panel B, WKY/Tac at 6 weeks of age clusters with theWKY groups of 5 months of age. WKY
and SHR less clearly separate, indicating a weaker relationship of gene expression with blood pressure. PC: principal component. Numbers in brackets:
contribution of the principal component to variability in the data, given as percentage.
doi:10.1371/journal.pone.0137027.g001
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vessels (comparing the expression at 5 months vs. 6 weeks) are listed in Table 3. Comparison
of WKY to SHR showed that at 6 weeks of age 87 genes were differentially expressed. At 5
months of age, 115 genes were differentially expressed. Of these, 39 genes were differentially
expressed at both time points (Fig 2D). A list of the most strongly up- and downregulated
genes that were present at both ages, in SHR as compared to WKY, is shown in Table 3.
Further confirmation of some of the top up- or downregulated miRNA and mRNA from
our microarray data was done by RT-PCR in mesenteric arteries fromWKY/NTac and
SHRSP/A3NCrl (Tables 2 and 3). Most differences could be confirmed (Tables 2 and 3).
IPA analysis
To elucidate molecular networks and cellular functions enriched for differentially expressed
miRNAs and mRNAs, we used the IPA software package. The miRNAs that were differentially
expressed with age in WKY involved molecular functions related to cell cycle and cellular
development, growth, proliferation, death or movement. In SHR, a much larger number of
miRNAs were found to be upregulated upon maturation, involving more genes in the same
clusters fromWKY (e.g. 24 versus 17 genes in cellular development). In addition, new clusters
appeared: inflammatory diseases, connective tissue disorders and metabolic diseases. The com-
parison between SHR and WKY showed the same molecular and cellular functions as
described above, with more miRNAs involved at 5 months than at 6 weeks (S1 Table).
The analysis of the mRNAs differentially expressed in WKY maturation revealed functions
related to cellular processes like growth, proliferation and movement. The top networks were
related to the same cellular functions but also to connective tissue disorders (S2 Table). In
SHR, the differentially expressed age-related genes were partly involved in the same cellular
functions as WKY. However, also here, distinct functions and networks were observed that
were specific for SHR maturation. For the mRNA analysis, these were related to metabolism
and cardiovascular system development and function. In the comparison of SHR and WKY,
the differentially expressed genes at 6 weeks were involved in cellular functions related to lipid
metabolism, small molecule biochemistry, molecular transport, and cellular movement or
Fig 2. Differences in miRNA andmRNA expression. Venn diagrams showing the number of miRNAs (A,
B) and mRNAs (C, D) that were significantly different in each comparison. Upper numbers (green) indicate
the number of up-regulated genes; lower numbers (red) indicate number of down-regulated genes.
doi:10.1371/journal.pone.0137027.g002
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proliferation. However, at 5 months, the biochemical and metabolic groups were no longer dif-
ferentially expressed. Groups that appeared here relate to cell signaling, morphology and cell
death. In the top networks as well as in the top physiological and developmental functions, a
large number of genes were related to cardiovascular system development and function (S3
Table).
Thbs4 and ER stress response genes
Since thrombospondin 4 (Thbs4) was the most overexpressed gene in the comparison between
SHR and WKY at both ages, it emerged as an interesting target for further study. Other studies
have shown that this protein is involved, among other processes, in the endoplasmic reticulum
(ER) stress response, by activating the transcription factor 6α (ATF6α), one of the main media-
tors in this process [15]. We checked the mRNA levels of both Atf6α and a large number of
downstream targets [12] in the microarray data and found a significant differential expression
Table 2. List of most strongly up- and down-regulatedmicroRNAs.
5 months vs. 6 weeks
WKY SHR
fold fold
miRNA array PCR miRNA array PCR
rno-miR-29b-3p 4.1 2.2* rno-miR-29b-3p 4.2 4.2
rno-miR-29a-3p 2.5 rno-miR-132-3p 2.9 2.3
rno-miR-29c-3p 2.3 rno-miR-34a-5p 2.6
rno-miR-29c-5p 2.0 rno-miR-29a-3p 2.6
rno-miR-194-5p 1.9 rno-miR-29c-5p 2.4
rno-miR-222-3p 1.8 rno-miR-29c-3p 2.4
rno-miR-598-3p 1.8 rno-miR-145-3p 2.1
rno-miR-7a-5p 1.8 rno-miR-222-3p 2.1
rno-miR-101a-3p 1.7 rno-miR-598-3p 2.0
rno-miR-192-5p 1.7 rno-miR-30c-2-3p 2.0
rno-miR-322-3p 0.5 rno-miR-434-3p 0.3
rno-miR-127-3p 0.4 rno-miR-450a-5p 0.3
rno-miR-450a-5p 0.4 rno-miR-299a-5p 0.3
rno-miR-181c-5p 0.4 rno-miR-411-3p 0.3
rno-miR-411-3p 0.4 rno-miR-127-3p 0.3
rno-miR-299a-5p 0.4 rno-miR-136-5p 0.3
rno-miR-322-5p 0.3 rno-miR-379-5p 0.2
rno-miR-379-5p 0.3 rno-miR-542-3p 0.2
rno-miR-542-3p 0.3 rno-miR-322-5p 0.2
rno-miR-542-5p 0.2 0.06* rno-miR-542-5p 0.1 0.02*
SHR vs. WKY
6 weeks 5 months
rno-miR-31a-5p 5.8 5.5 rno-miR-31a-3p 2.8 7.8*
rno-miR-31a-3p 3.5 16.9* rno-miR-146a-5p 0.5 0.3*
The upper part lists miRNAs that are differentially expressed upon maturation in WKY and SHR (5 months vs. 6 weeks; adjusted P-value <0.05).
Maturation shows many similarities in WKY and SHR, with some exceptions such as miR-132-3p. The lower part of the table shows a direct comparison
between SHR and WKY, which yielded only 3 miRNAs that were signiﬁcantly differentially expressed. Fold change obtained during PCR conﬁrmation is
also shown (* p <0.05, n = 5–6).
doi:10.1371/journal.pone.0137027.t002
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Table 3. List of most strongly up- and down-regulatedmRNAs.
Systematic name Gene
Symbol
Gene name Fold change
array PCR Ratio
WKY SHR SHR SHR/
WKY
Speciﬁc for WKY maturation
NM_031116 Ccl5 chemokine (C-C motif) ligand 5 6.9 2.1 0.3
Speciﬁc for SHR maturation
NM_017210 Dio3 deiodinase, iodothyronine, type III 1.5 7.2 2.3 4.7
NM_022604 Esm1 endothelial cell-speciﬁc molecule 1 2.4 8.8 2.1 3.7
NM_021586 Ltbp2 latent transforming growth factor beta binding protein 2 0.8 3.0 3.6
NM_031598 Pla2g2a phospholipase A2, group IIA 2.5 8.7 3.5
NM_133306 Olr1 oxidized low density lipoprotein (lectin-like) receptor 1 1.6 5.0 3.1
ENSRNOT00000030320 Mmrn1 multimerin 1 0.9 0.3 0.3
NM_019157 Aqp7 aquaporin 7 1.2 0.4 0.3
NM_012789 Dpp4 dipeptidylpeptidase 4 1.1 0.3 0.3
NM_134349 Mgst1 microsomal glutathione S-transferase 1 1.0 0.3 0.3
NR_027324 H19 H19, imprinted maternally expressed transcript 0.3 0.1 0.3
NM_012777 Apod apolipoprotein D 0.6 0.1 0.2
NM_030865 Myoc myocilin 0.9 0.2 0.2







NM_017133 Thbs4 thrombospondin 4 4.2 9.2 14.1*
NM_001008833 RT1-CE10 RT1 class I, locus CE10 5.6 6.4
NM_001257345 Pcmtd1 protein-L-isoaspartate (D-aspartate) O-methyltransferase
domain containing 1
5.5 4.7 0.3
NM_001107564 Ano1 anoctamin 1, calcium activated chloride channel 2.8 3.5 7.7
NM_001039197 Tor1b torsin family 1, member B 2.0 3.0
NM_053535 Enpp1 ectonucleotide pyrophosphatase/phosphodiesterase 1 3.2 2.9 0.7
NM_198791 Tlr3 toll-like receptor 3 2.7 2.7
NM_001008841 RT1-CE3 RT1 class I, locus CE3 3.0 2.5
NM_001012174 Fkbp5 FK506 binding protein 5 3.4 2.3
NM_001012218 Trim55 tripartite motif-containing 55 0.3 0.3
NM_001008858 RT1-T24-1 RT1 class I, locus T24, gene 1 0.3 0.3
NM_001008843 RT1-CE5 RT1 class I, locus CE5 0.4 0.2
NM_001025038 Mettl24 methyltransferase like 24 0.3 0.1 5.8 E-6*
NM_001004084 RT1-Bb RT1 class II, locus Bb 0.2 0.1
NM_001013853 LOC287167 globin, alpha 0.1 0.1 4.7 E-6*
NM_001107284 Slitrk5 SLIT and NTRK-like family, member 5 0.1 0.1 1.8 E-5*
NM_001127530 LOC302022 similar to nidogen 2 protein 0.2 0.1 0.5
Upper part: genes speciﬁcally associated with maturation in either WKY or SHR (adjusted P-value <0.05). Fold changes (5 months vs. 6 weeks) are listed,
as well as the ratio SHR/WKY). Lower part: differentially expressed between WKY and SHR at both ages (6 weeks and 5 months). Fold change obtained
during PCR conﬁrmation is also shown (* p <0.05, n = 5–6).
doi:10.1371/journal.pone.0137027.t003
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in SHR vs WKY at both 6 weeks (P = 0.003) and 5 months (P = 0.04) (Fig 3A). Since changes at
the mRNA level do not necessarily translate to differences at the protein level, we analyzed aor-
tic homogenates that were obtained from the same animals by western blotting. These data
confirmed our microarray results, as we found a significant increase at the protein level of
THBS4, the cleaved (active) form of ATF6α, and one of its downstream targets, mesencephalic
astrocyte-derived neurotrophic factor (MANF) in SHR as compared to WKY (Fig 3C–3E). For
another downstream target, the protein disulfide isomerase (PDI), there was a tendency of
upregulation although this was not significant (Fig 3F). In sections of mesenteric arteries,
THBS4 was localized in the cytoplasm of smooth muscle cells (Fig 3G).
Discussion
The objective of the current study was to investigate gene expression in the development of
hypertension in mesenteric arteries of SHR as compared to WKY by miRNA and mRNA
microarray analysis and bioinformatical tools. Three sublines of SHR and WKY were used to
identify genes with consistent up or down regulation in hypertension, and two time points (6
weeks and 5 months) were analyzed. Limitations of our study were that we used mesenteric
arteries (approximately 350 micrometer in diameter) that are at the upper end of the range of
vessels that contribute to peripheral resistance [16]. In addition, it should be noted that
Fig 3. Thrombospondin 4 and ER stress related genes in SHR vessels. Fold changes of genes related to ER stress in the array data in SHR vsWKY at 6
weeks and 5 months (A). Image of a western blot with WKY (left) and SHR (right) aorta samples (B) and quantifications for thrombospondin 4 (THBS4) (C),
the activated form of the transcription factor 6α (ATF6α) (D), mesencephalic astrocyte-derived neurotrophic factor (MANF) (E) and protein disulfide
isomerase (PDI) (F) (n = 5). Localization of THBS4 by staining in mesenteric artery cross sections: THBS4 (red), nuclei (blue), elastic internal lamina (green)
(G). (*p<0.05; **p<0.01; ***p<0.001).
doi:10.1371/journal.pone.0137027.g003
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differences in gene expression are likely to exist between vascular beds and perhaps even
among vessels from different branching orders, as large and small resistance arteries are known
to be heterogeneous [17].
Maturation in WKY and SHR
Principal component analysis (PCA) showed that gene expression profiles are strongly age-
related. The maturation of WKY and SHR vessels showed considerable overlap in terms of
miRNA and mRNA expression profiles. Thus, maturation in both WKY and SHR vessels was
associated with a prominent increase in expression of the miR-29 family. MiR-29 has previ-
ously been related to aging and dilation of the aorta, associated with down-regulation of extra-
cellular matrix molecules [18]. This is confirmed by a recent study where miR-29b was related
to a reduction in extracellular matrix proteins as shown by a proteomic approach [19]. In the
present study the mRNA microarray experiment showed that many of the targets of miR-29
were indeed significantly down-regulated, both in WKY and SHR. In fact, expression of many
extracellular matrix proteins such as collagens and elastin decreased with vascular maturation.
Most specific for maturation of SHR vessels at the miRNA level was the up-regulation of miR-
132-3p. MiR-132 is one of the microRNAs that is up-regulated by angiotensin II. Its upregula-
tion is related to cell cycle, motility, and cardiovascular functions [20], which is in agreement
with the IPA analysis where the same pathways were identified. This miRNA therefore seems
an interesting target for further studies.
Analysis of differentially expressed genes with IPA software showed that among the age
related genes for WKY and SHR, the number of genes involved in functions like proliferation,
cell movement or cardiovascular system development and function that reached statistical sig-
nificance, was larger in SHR. Specifically for SHRmaturation a group of genes related to metab-
olism of lipids, drugs and carbohydrates as well as small molecule biochemistry emerged from
the analysis. This includes genes such as phospholipase A2 group IIA, oxidized low density lipo-
protein receptor 1 and apolipoprotein D, suggesting alterations in metabolism in SHR as com-
pared to WKY. In addition to these genes, interesting new candidates specific for maturation of
SHR emerged from the mRNA analysis. The most strongly upregulated was the type III deiodi-
nase (Dio3). This is a fetally expressed thyroid hormone-inactivating enzyme associated with
cell proliferation, which was recently shown to be up-regulated in the spared part of the myocar-
dium after infarction [21]. Its main substrate, the triiodothyronine (T3 thyroid hormone), has
been reported to have effects in the relaxation of mesenteric arteries [22]. The second specific
gene was Esm1 or endocan, which recently has been proposed as new marker in essential hyper-
tension [23]. Thus, a number of interesting miRNAs, genes and processes such as proliferation,
migration, and metabolism are linked to maturation, with some being specific for SHR.
Both at the miRNA and mRNA level a more extensive age-related change in expression pro-
file was noted in SHR as compared to WKY. Based on this, one could argue that hypertension
is associated with the up- or downregulation of many more genes during development. How-
ever, another possible reason for this difference could be a larger heterogeneity among WKY
sublines. This can be seen in the PCA and clustering for both miRNAs and mRNAs, where
SHR sublines appear more homogeneous. Thus, at the miRNA level the WKY/NHsd separated
from the other WKY sublines. At the mRNA level, the WKY/NTac at 6 weeks of age clustered
with the 5 months old WKY groups. In a previous study we observed a similar high variability
of vascular function and structure in these sublines [8]. The heterogeneity in WKY has also
been pointed out by other groups, at the genetic [24] and phenotypic [25] level. This seems to
be caused by the distribution of the rats before they were fully inbred, contrary to SHR animals
[24].
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Comparison of WKY to SHR
At the miRNA level, a direct comparison between SHR and WKY yielded remarkably few dif-
ferences. Again, this may relate to heterogeneity among sublines of rats. Analysis of the com-
parison between SHR and WKY revealed a number of molecules involved in cell growth and
proliferation pathways, suggesting that these differentially expressed miRNAs could be
involved in the regulation of proliferation in hypertension. This is consistent with the up-regu-
lation of miR-31a-3p and -5p and down-regulation of miR-146a-5p in SHR as compared to
WKY. Recent work shows that miR-31 controls smooth muscle phenotype and proliferation
[26]. MiR-31 is an abundant miRNA in vascular smooth muscle cells, and its expression is sig-
nificantly increased in proliferative smooth muscle cells and in vascular walls with neointimal
growth [26]. Thus, the increased expression of miR-31a-3p/5p in the present study seems to be
in accordance with the increased wall thickness and number of smooth muscle layers in SHR
in our previous work [8]. It should however be noted that the increase in expression of miR-
31a-3p/5p may, in part, be a consequence of differences in the ratio of smooth muscle cells
over endothelial cells and/or other cell types. MiR-146a, which was downregulated in the cur-
rent study, has also been related to cardiovascular disease. However, in contrast to our study,
miR-146a was found to be up-regulated in human atherosclerosis [27]. In vitro data suggest
that this microRNA increases smooth muscle proliferation [28]. In endothelial cells, down-reg-
ulation of miR-146a is associated with production of extracellular matrix proteins in the con-
text of diabetes [29].
Regarding mRNA expression, in the comparison between SHR andWKY, the top gene net-
work was related to metabolism. Also in this comparison, a large number of genes was involved
in cellular growth and proliferation or cellular movement, as seen in the SHR maturation. This
is in agreement with the increase in wall thickness that we previously found in SHR [8]. It is
also remarkable that a number of genes that are differentially expressed were related to the
immune system. Although at first sight this could suggest an ongoing inflammatory processes,
typical markers of inflammation and leukocyte infiltration such as CD68 did not emerge in our
study. It is therefore more likely that differences in the expression of these immune related
genes are consequence of the genetic differences between WKY and SHR.
ER stress
The most significantly upregulated gene in SHR vessels as compared to WKY at both ages was
thrombospondin 4 (Thbs4). This protein is frequently considered to be an extracellular matrix
protein. It was recently identified as a mechano-signaling molecule in the heart [30]. It has
been shown to be up-regulated in the heart during pressure overload, where it is expressed in
various tissues including blood vessels [31]. In the latter study, it was shown to limit inflamma-
tion and fibrosis in the heart, indicating that it plays an important role in matrix remodeling.
However, in our hands, immunostaining revealed that THBS4 is mainly located intracellularly.
This is more consistent with a second important role attributed to THBS4, the ER stress
response via ATF6α in heart [15]. We therefore focused on this pathway, and further investi-
gated ATF6α and its downstream targets.
ER stress leads to misfolding and aggregation of proteins in the ER lumen. Recently, several
studies have pointed out a link between hypertension and ER stress. Thus, ER stress inhibitor
treatment decreased blood pressure, as well as aortic apoptosis, collagen content and fibrosis in
aortas of Ang II infused Sprague Dawley rats [32]. The ER stress inducer tunicamycin increases
blood pressure and vascular smooth muscle contractility [33]. In SHR, suppression of ER stress
normalizes endothelium-derived contracting factors (EDCF)-mediated contractions in the
aorta of the SHR [34]. The strong up-regulation of Thbs4 led us to analyze 23 targets of ATF6α
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which indeed showed a clear pattern of up-regulation of the whole ER stress signaling pathway.
Further analysis of the expression of THBS4, the cleaved form of ATF6α, and two of its targets
by western blot confirmed the up-regulation of this pathway at the protein level in hyperten-
sion. In addition to this, another of the top upregulated genes in the array, the Tor1b (torsin
family 1, member B) belongs to a family of proteins present in the membrane of the ER that
has also been related to ER stress [35–38]. Thus, our data support the hypothesis that ER stress
plays an important role in hypertension, particularly at the level of the resistance arteries.
Conclusions
Taken together, miRNA and mRNA expression analysis identified a large number of miRNAs
and genes in resistance arteries that are differentially expressed upon maturation, some of
which are specifically related to the development of hypertension. Those genes are mainly
involved in extracellular matrix, vascular tone, metabolism, and in cell proliferation and
growth processes. We report new miRNAs and genes of interest for further research in hyper-
tension. One of these is Thbs4, which appears to play a role in ER stress associated with
hypertension
Supporting Information
S1 Table. IPA results for miRNAmicroarray data. Groups with the most relevant number of
miRNAs for the different categories in the IPA core analysis. # molecules is the number of miR-
NAs involved in a certain group. In the top networks, the score is calculated by the software
using Fisher’s exact test and defined as: p-score = -log10(p-value).
(PDF)
S2 Table. IPA results for mRNAmicroarray data in 5 months vs 6 weeks comparison.
Groups with the most relevant number of mRNAs for the different categories in the IPA core
analysis for 5 months vs 6 weeks comparison in WKY and SHR animals. # molecules is the
number of mRNAs involved in a certain group. In the top networks, the score is calculated by
the software using Fisher’s exact test and defined as: p-score = -log10(p-value).
(PDF)
S3 Table. IPA results for mRNAmicroarray data in SHR vs WKY comparison. Groups with
the most relevant number of mRNAs for the different categories in the IPA core analysis for
SHR vs WKY comparison at both ages. # molecules is the number of miRNAs involved in a
certain group. In the top networks, the score is calculated by the software using Fisher’s exact
test and defined as: p-score = -log10(p-value).
(PDF)
Author Contributions
Conceived and designed the experiments: GG EvB ENTPB. Performed the experiments: TP KS
JdV AvW GG ENTPB. Analyzed the data: TP KS AJ PDM EvB ENTPB. Contributed reagents/
materials/analysis tools: SMA. Wrote the paper: TP ENTPB EvB.
References
1. Schiffrin EL. Remodeling of resistance arteries in essential hypertension and effects of antihypertensive
treatment. American Journal of Hypertension. 2004; 17(12):1192–200. PMID: 15607629
2. Okuda T, Sumiya T, Muzutani K, Tago N, Miyata T, Tanabe T, et al. Analyses of differential gene
expression in genetic hypertensive rats by microarray. Hypertension Research. 2002; 25(2):249–55.
PMID: 12047041
Gene and MicroRNA Expression in SHR Small Arteries
PLOS ONE | DOI:10.1371/journal.pone.0137027 September 10, 2015 14 / 16
3. Okuda T, Sumiya T, Iwai N, Miyata T. Difference of gene expression profiles in spontaneous hyperten-
sive rats andWistar-Kyoto rats from two sources. Biochemical and Biophysical Research Communica-
tions. 2002; 296(3):537–43. PMID: 12176014
4. Ashenagar MS, Tabuchi M, Kinoshita K, Ooshima K, Niwa A, Watanabe Y, et al. Gene expression in
the adrenal glands of three spontaneously hypertensive rat substrains. Molecular Medicine Reports.
2010; 3(2):213–22. doi: 10.3892/mmr_00000242 PMID: 21472224
5. HuWY, Fukuda N, Kanmatsuse K. Growth characteristics, angiotensin II generation, and microarray-
determined gene expression in vascular smooth muscle cells from young spontaneously hypertensive
rats. Journal of Hypertension. 2002; 20(7):1323–33. PMID: 12131529
6. Grayson TH, Ohms SJ, Brackenbury TD, Meaney KR, Peng K, Pittelkow YE, et al. Vascular microarray
profiling in two models of hypertension identifies caveolin-1, Rgs2 and Rgs5 as antihypertensive tar-
gets. Bmc Genomics. 2007; 8.
7. Unthank JL, McClintick JN, Labarrere CA, Li L, Distasi MR, Miller SJ. Molecular basis for impaired col-
lateral artery growth in the spontaneously hypertensive rat: insight frommicroarray analysis. Physiolog-
ical reports. 2013; 1(2):e0005–e. doi: 10.1002/phy2.5 PMID: 24303120
8. Bakker ENTP, Groma G, Spijkers LJA, de Vos J, vanWeert A, van Veen H, et al. Heterogeneity in Arte-
rial Remodeling among Sublines of Spontaneously Hypertensive Rats. PloS one. 2014; 9(9):e107998–
e. doi: 10.1371/journal.pone.0107998 PMID: 25251068
9. Okamoto K, Aoki K. Development of a strain of spontaneously hypertensive rats. Japanese circulation
journal. 1963; 27:282–93. PMID: 13939773
10. Lopez-Romero P. Pre-processing and differential expression analysis of Agilent microRNA arrays
using the AgiMicroRna Bioconductor library. Bmc Genomics. 2011; 12.
11. Ritchie ME, Silver J, Oshlack A, Holmes M, Diyagama D, Holloway A, et al. A comparison of back-
ground correction methods for two-colour microarrays. Bioinformatics. 2007; 23(20):2700–7. PMID:
17720982
12. Adachi Y, Yamamoto K, Okada T, Yoshida H, Harada A, Mori K. ATF6 Is a Transcription Factor Spe-
cializing in the Regulation of Quality Control Proteins in the Endoplasmic Reticulum. Cell Structure and
Function. 2008; 33(1):75–89. PMID: 18360008
13. WuD, Lim E, Vaillant F, Asselin-Labat ML, Visvader JE, Smyth GK. ROAST: rotation gene set tests for
complex microarray experiments. Bioinformatics.2010; 26(17):2176–82. doi: 10.1093/bioinformatics/
btq401 PMID: 20610611
14. Turczyńska KM, Swärd K, Hien TT, Wohlfahrt J, Mattisson IY, EkmanM, et al. Regulation of Smooth
Muscle Dystrophin and Synaptopodin 2 Expression by Actin Polymerization and Vascular Injury. Arte-
riosclerosis, Thrombosis, and Vascular Biology.2015; 35: 1489–1497 doi: 10.1161/ATVBAHA.114.
305065 PMID: 25857312
15. Lynch JM, Maillet M, Vanhoutte D, Schloemer A, Sargent MA, Blair NS, et al. A thrombospondin-depen-
dent pathway for a protective ER stress response. Cell. 2012; 149(6):1257–68. doi: 10.1016/j.cell.
2012.03.050 PMID: 22682248
16. Christensen KL, Mulvany MJ. Location of resistance arteries. Journal of Vascular Research. 2001; 38
(1):1–12. PMID: 11173989
17. Hadoke PWF, McIntyre CA, Gray GA, Buckley CH. Functional heterogeneity of large and small resis-
tance arteries isolated from biopsies of subcutaneous fat—Implications for investigation of vascular
pathophysiology. General Pharmacology. 2000; 35(3):119–27. PMID: 11744233
18. Boon RA, Seeger T, Heydt S, Fischer A, Hergenreider E, Horrevoets AJG, et al. MicroRNA-29 in Aortic
Dilation: Implications for Aneurysm Formation. Circulation research. 2011; 109(10):1115–U66. doi: 10.
1161/CIRCRESAHA.111.255737 PMID: 21903938
19. Abonnenc M, Nabeebaccus AA, Mayr U, Barallobre-Barreiro J, Dong X, Cuello F, et al. Extracellular
Matrix Secretion by Cardiac Fibroblasts Role of MicroRNA-29b and MicroRNA-30c. Circulation
research. 2013; 113(10):1138–+. doi: 10.1161/CIRCRESAHA.113.302400 PMID: 24006456
20. Jin W, Reddy MA, Chen Z, Putta S, Lanting L, Kato M, et al. Small RNA Sequencing Reveals Micro-
RNAs That Modulate Angiotensin II Effects in Vascular Smooth Muscle Cells. Journal of Biological
Chemistry. 2012; 287(19):15672–83. doi: 10.1074/jbc.M111.322669 PMID: 22431733
21. Janssen R, Zuidwijk M, Muller A, Mulders J, Oudejans CBM, Simonides WS. Cardiac Expression of
Deiodinase type 3 (Dio3) Following Myocardial Infarction Is Associated With the Induction of a Pluripo-
tency microRNA Signature from the Dlk1-Dio3 Genomic Region. Endocrinology. 2013; 154(6):1973–8.
doi: 10.1210/en.2012-2017 PMID: 23554452
22. Zwaveling J, Pfaffendorf M, vanZwieten PA. The direct effects of thyroid hormones on rat mesenteric
resistance arteries. Fundamental & Clinical Pharmacology. 1997; 11(1):41–6.
Gene and MicroRNA Expression in SHR Small Arteries
PLOS ONE | DOI:10.1371/journal.pone.0137027 September 10, 2015 15 / 16
23. Balta S, Mikhailidis DP, Demirkol S, Ozturk C, Kurtoglu E, Demir M, et al. Endocan-A Novel Inflamma-
tory Indicator in Newly Diagnosed Patients With Hypertension: A Pilot Study. Angiology. 2014; 65
(9):773–7. doi: 10.1177/0003319713513492 PMID: 24402320
24. Kurtz TW, Montano M, Chan L, Kabra P. Molecular evidence of genetic-heterogeneity in wistar-kyoto
rats—implications for research with the spontaneously hypertensive rat. Hypertension. 1989; 13
(2):188–92. PMID: 2914738
25. Kurtz TW, Morris RC. Biological variability in wistar-kyoto rats—implications for research with the spon-
taneously hypertensive rat. Hypertension. 1987; 10(1):127–31. PMID: 3596765
26. Liu X, Cheng Y, Chen X, Yang J, Xu L, Zhang C. MicroRNA-31 Regulated by the Extracellular Regu-
lated Kinase Is Involved in Vascular Smooth Muscle Cell Growth via Large Tumor Suppressor Homolog
2. Journal of Biological Chemistry. 2011; 286(49):42371–80. doi: 10.1074/jbc.M111.261065 PMID:
22020941
27. Raitoharju E, Lyytikainen L-P, Levula M, Oksala N, Mennander A, Tarkka M, et al. miR-21, miR-210,
miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular
Study. Atherosclerosis. 2011; 219(1):211–7. doi: 10.1016/j.atherosclerosis.2011.07.020 PMID:
21820659
28. Sun S-g, Zheng B, Han M, Fang X-m, Li H-x, Miao S-b, et al. miR-146a and Kruppel-like factor 4 form a
feedback loop to participate in vascular smooth muscle cell proliferation. Embo Reports. 2011; 12
(1):56–62. doi: 10.1038/embor.2010.172 PMID: 21109779
29. Feng B, Chen S, McArthur K, Wu Y, Sen S, Ding Q, et al. miR-146a-Mediated Extracellular Matrix Pro-
tein Production in Chronic Diabetes Complications. Diabetes. 2011; 60(11):2975–84. doi: 10.2337/
db11-0478 PMID: 21885871
30. Cingolani OH, Kirk JA, Seo K, Koitahashi N, Lee D-i, Ramirez-Correa G, et al. Thrombospondin-4 Is
Required for Stretch-Mediated Contractility Augmentation in Cardiac Muscle. Circulation research.
2011; 109(12):1410–4. doi: 10.1161/CIRCRESAHA.111.256743 PMID: 22034490
31. Frolova EG, Sopko N, Blech L, Popovic ZB, Li J, Vasanji A, et al. Thrombospondin-4 regulates fibrosis
and remodeling of the myocardium in response to pressure overload. FASEB journal: official publica-
tion of the Federation of American Societies for Experimental Biology. 2012; 26(6):2363–73.
32. Spitler KM, Webb RC. Endoplasmic Reticulum Stress Contributes to Aortic Stiffening via Proapoptotic
and Fibrotic Signaling Mechanisms. Hypertension. 2014; 63(3):E40–E5. doi: 10.1161/
HYPERTENSIONAHA.113.02558 PMID: 24379182
33. Liang B, Wang S, Wang Q, ZhangW, Viollet B, Zhu Y, et al. Aberrant Endoplasmic Reticulum Stress in
Vascular Smooth Muscle Increases Vascular Contractility and Blood Pressure in Mice Deficient of
AMP-Activated Protein Kinase-alpha 2 In Vivo. Arteriosclerosis Thrombosis and Vascular Biology.
2013; 33(3):595.
34. Spitler KM, Matsumoto T, Webb RC. Suppression of endoplasmic reticulum stress improves endothe-
lium-dependent contractile responses in aorta of the spontaneously hypertensive rat. American Journal
of Physiology-Heart and Circulatory Physiology. 2013; 305(3):H344–H53. doi: 10.1152/ajpheart.
00952.2012 PMID: 23709602
35. O'Farrell C, Lockhart PJ, Lincoln S, De Lucia M, Singleton AB, Dickson DW, et al. Biochemical charac-
terization of torsinB. Brain research Molecular brain research. 2004; 127(1–2):1–9. PMID: 15306116
36. Rose AE, Zhao C, Turner EM, Steyer AM, Schlieker C. Arresting a Torsin ATPase Reshapes the Endo-
plasmic Reticulum. Journal of Biological Chemistry. 2014; 289(1):552–64. doi: 10.1074/jbc.M113.
515791 PMID: 24275647
37. Chen P, Burdette AJ, Porter JC, Ricketts JC, Fox SA, Nery FC, et al. The early-onset torsion dystonia-
associated protein, torsinA, is a homeostatic regulator of endoplasmic reticulum stress response.
Human Molecular Genetics. 2010; 19(18):3502–15. doi: 10.1093/hmg/ddq266 PMID: 20584926
38. Hewett J, Ziefer P, Bergeron D, Naismith T, Boston H, Slater D, et al. TorsinA in PC12 cells: Localiza-
tion in the endoplasmic reticulum and response to stress. Journal of Neuroscience Research. 2003; 72
(2):158–68. PMID: 12671990
Gene and MicroRNA Expression in SHR Small Arteries
PLOS ONE | DOI:10.1371/journal.pone.0137027 September 10, 2015 16 / 16
